Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Discover the pros and cons of long term versus short term investing. Make informed decisions based on your financial goals.
28,015 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Investors eyeing $20,000 a month in dividend income must balance capital, yield, and risk as market conditions shift ...
Dividend income can weather downturns better than stocks, but it isn’t immune. This report explains why payouts hold ...
Bitcoin hovers around the $60,000 level as traders question the significance of the 200-day moving average. K33 sugge...
A nobel laureate economist warns that anxiety about AI displacing workers risks shaping real outcomes, not just headl...
U.S. XRP ETF inflows remain near zero in mid-July as institutional appetite cools and on-chain activity moderates, ke...
Oil prices rose above $100 a barrel after a large emergency stockpile release. Yet investor fears lingered about supp...
Economists say AI is weighing on hiring in the U.S. as the labor market cools, signaling a shift for workers and comp...
A weekend heat wave has buckled the Autobahn near Berlin and halted long-distance trains, upending travel plans and r...
When headlines scream spacex stock drop again, investors scramble for what really moved the price. This article break...
A $1 million retirement portfolio anchors a stable income, but taxes, inflation and market shifts shape actual take-h...
As SpaceX moves toward a historic public listing, Antonio Gracias could see his private stake surge into the tens of ...